A team of scientists from King’s College London (KCL), UK, created an unexpected performance when exposed tumors of colorectal cancer to galactoside-binding protein (βGBP).

This protein rapidly promotes tumor suppressive properties, triggering the "suicide" of malignant cells.

Not only that, the cancer cells that escape the "suicide" force are also pulled out of hiding by the protein, causing them to expose themselves to the immune system, thereby helping the body to create an anti-response. Strong cancer, prevent the disease from recurring. This protein can be applied to malignant colorectal tumors and some other resistant cancers.

After that, βGBP continued to be tested on mice and gave positive results. It has almost no side effects because it is a natural component of the patient's own immune system.

Not only does it help kill cancer, it can provide long-term protection for patients by stimulating the body's immune monitoring of cancer. The researchers hope to soon be able to progress to clinical trials on humans. If it continues to be successful, this will be a promising and advanced type of cancer treatment based on immunotherapy.

According to: VTV1